Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Joshua Hexter

COO at Oramed Pharmaceuticals Inc. (ORMP)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $746K

Reported trades

Filed Stock Type Shares Price Value Since
Oct 2SEC ORMPOramed Pharmaceuticals Inc. Sell Plan 30,0001,328,130 held (−2%) $4.51 $135K -9.8%
Jul 2SEC ORMPOramed Pharmaceuticals Inc. Sell Plan 137,0001,023,384 held (−12%) $4.46 $611K -8.7%
  • Sell

    COO Joshua Hexter sold $135K of ORMP at $4.51 — pre-scheduled 10b5-1 plan sale.

  • Sell

    COO Joshua Hexter sold $611K of ORMP at $4.46 — pre-scheduled 10b5-1 plan sale.